An early pilot study has shown that special analysis of the lens of the eye by a newly developed biomicroscope could be able to predict Type 2 diabetes.
In a new study, researchers from Osaka University (Japan) have demonstrated that measuring methylation of microRNA could accurately distinguish individuals with early pancreatic cancer from healthy controls.
A new device, termed the MasSpec Pen, has been developed to more effectively identify tumor margins during tumor removal surgeries.
Wearable skin sensors provide real-time measurements of electrolytes and metabolites in perspiration
Wearable skin sensors developed by researchers at the University of California (Berkeley, USA) could be able to provide real-time updates on dehydration and fatigue by providing measurements of electrolytes and metabolites in perspiration as well as record perspiration rates.
A new proteomics technique, termed ubiquitin clipping, has been developed to further understanding of changes that control protein function and their role in healthy and disease states.
A novel microarray has been developed by researchers that incorporates both physical and electrostatic features to improve diagnostic methods for cervical cancer.
A novel artificial intelligence and biosensor device has been developed to monitor if live cancer cells remain after chemotherapy treatment.
In this interview, Stephanie Traub (Cancer Research UK; London, UK) discusses her work as a biomarker specialist and the challenges she faces when developing biomarker strategies.
A prototype wearable device has been developed to continuously collect live cancer cells directly from a patient’s blood, presenting an alternative to biopsies.
A new microfluidics device has been developed that could detect individual cancer cells in blood and has the potential to be used for liquid biopsies.